Dr. Christopher C. Roth, M.D.
Urology (Pediatric Urology Physician)
At a glance
- Years since graduation
- 24
- In the NPI registry since
- 2007
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pediatric Urology Physician primary
LA license 026088 · FL license ME133119
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Childrens Hospital New Orleans, LA
Medical groups
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Oxybutynin Chloride Er (oxybutynin chloride) Other prescribers in New Orleans, LA | 35 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 5 companies reported 8 payments worth $356 in total to this clinician.
| Novo Nordisk Inc | $151 |
|---|---|
| Coloplast Corp | $83.34 |
| Teleflex LLC | $56.01 |
| 180 Medical, Inc. | $48.99 |
| Alnylam Pharmaceuticals Inc. | $16.14 |
| Food and Beverage | $356 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $8,235 in research payments for these studies, mostly to the institutions running them.
- Open-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CIC
Sumitomo Pharma America, Inc. · Recruiting · NCT05491525
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.